CEP290 Antikörper (Internal Region)
Kurzübersicht für CEP290 Antikörper (Internal Region) (ABIN570714)
Target
Alle CEP290 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- Internal Region
-
Verwendungszweck
- CEP290
-
Sequenz
- RNSKHLKQQQ YRAEN
-
Spezifität
- Despite similarity of the immunizing peptide with the mouse protein, this antibody was demonstrated to weak for mouse Cep290.
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence C-RNSKHLKQQQYRAEN , from the internal region of the protein sequence according to NP_079390.3.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Immunohistochemistry: Paraffin embedded Human Prostate. Recommended concentration: 5-7 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:128000.
-
Kommentare
-
Immunocytochemistry: Formaldehyde-fixed cell lines derived from Prostate Cancer and from Breast Cancer show typical centrosomal staining. Recommended concentration: 2-3ug/ml.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- CEP290 (Centrosomal Protein 290kDa (CEP290))
-
Andere Bezeichnung
- CEP290
-
Hintergrund
- CEP290, centrosomal protein 290 kDa, 3H11Ag, BBS14, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, monoclonal antibody 3H11 antigen, nephrocytsin-6, prostate cancer antigen T21
-
Gen-ID
- 80184, 216274
-
NCBI Accession
- NP_079390
-
Pathways
- cAMP Metabolic Process, M Phase
Target
-